GeneDx Holdings Corp. (WGS) Stock Analysis

Sector: HEALTHCARE - DIAGNOSTICS & RESEARCH

Exchange: NASDAQ

Key Metrics

• Price: $81.38
• Market Cap: $2.28B
• P/E Ratio: 717.27
• EPS: $0.11
• 52-Week High: $170.87
• 52-Week Low: $55.17

Market Sentiment

GeneDx Holdings Corp. currently has a Bullish sentiment score of 0.31.

About GeneDx Holdings Corp.

GeneDx Holdings Corp., headquartered in Stamford, Connecticut, stands at the forefront of genomic diagnostics, emphasizing precision medicine through its advanced genetic testing solutions. The company is dedicated to providing groundbreaking diagnostic services that deepen the understanding of genetic conditions, thereby empowering healthcare providers and patients to make informed choices. With a diverse array of tests and a strong focus on technological integration, GeneDx is strategically...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for GeneDx Holdings Corp. and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does WGS pay dividends?

GeneDx Holdings Corp. (WGS) does not currently pay a regular dividend.

What is WGS's P/E ratio?

GeneDx Holdings Corp. has a price-to-earnings (P/E) ratio of 717.27.

What is WGS's market cap?

GeneDx Holdings Corp. (WGS) has a market capitalization of $2.28B with a current stock price of $81.38.